Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Hematology
•
Diabetes
•
Endocrinology
Do you routinely monitor INR when starting GLP1 R agonist therapy on patients taking warfarin?
Related Questions
How do you counsel patients on the use of compounded weight loss medications?
When and how should we be stopping GLP-1 Receptor Agonist/Dual Agonist therapy?
Under what circumstances would you test for hypercortisolism in a patient with insulin resistance?
How do you adjust your HbA1c goal for managing diabetes in elderly patients with multiple chronic illnesses but no limitations in performing self-care tasks?
Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?
Are recurrent UTIs a contraindication to SGLT2i use?
Is there any benefit of using aspirin to mitigate VTE risk in testosterone-induced polycythemia?
Is Metformin contraindicated in patients using long term oxygen therapy at home?
Should GLP1 R agonists be used as first line glucose lowering agents in patients with ESKD and DM2?
Is ABI (Ankle Brachial index) lower limb arterial doppler not recommended if patient already has arterial stents in the legs, and if so, what other imaging modality would you consider as first-line?
